These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5411538)

  • 1. The relationship between some anticonvulsants and tumors of the blood forming organs.
    Bercel NA; Henstell HH
    Bull Los Angeles Neurol Soc; 1970 Jan; 35(1):21-4. PubMed ID: 5411538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudo-lymphomas and lymphomas induced by hydantoins].
    Reiffers J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):131-7. PubMed ID: 353727
    [No Abstract]   [Full Text] [Related]  

  • 3. Agranulocytosis following phenytoin-induced hypersensitivity syndrome.
    Ito S; Shioda M; Sasaki K; Imai K; Oguni H; Osawa M
    Brain Dev; 2009 Jun; 31(6):449-51. PubMed ID: 18774664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of phenytoin hypersensitivity syndrome.
    Monks G; Crowson AN; Cornelison R; Naylor M
    J Drugs Dermatol; 2002 Sep; 1(2):199-201. PubMed ID: 12847747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hematological complications in antiepileptic therapy. (Review of the literature and own experience)].
    Svatý J
    Cesk Pediatr; 1970 Apr; 25(4):193-7. PubMed ID: 5467640
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pseudolymphoma syndrome].
    Leiber B; Olbrich G
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):398. PubMed ID: 5082810
    [No Abstract]   [Full Text] [Related]  

  • 7. A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants.
    Duggan MA; Court JB
    Ann Clin Res; 1981 Dec; 13(6):406-18. PubMed ID: 6127980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphadenopathies and protein anomalies following phenylhydantoine therapy].
    Vesin P; Periac P; Kalifat R; Intrator L; Tuilliez M; Cattan D
    Nouv Presse Med; 1976 Apr; 5(17):1125-7. PubMed ID: 1084517
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hydantoin-induced lymphadenopathy].
    Celikic S
    Srp Arh Celok Lek; 1973 Feb; 101(2):173-7. PubMed ID: 4207031
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulomatous lymphadenopathy secondary to phenytoin therapy.
    Ovallath S; Remya RK; Kumar C; Nayanar S
    Seizure; 2013 Apr; 22(3):240-1. PubMed ID: 23280271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lymphadenopathies caused by drugs].
    Krasznai G; Szegedi G
    Orv Hetil; 1969 Nov; 110(48):2797-802. PubMed ID: 4903568
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin induced severe agranulocytosis and hepatitis.
    Kakar A; Byotra SP
    J Assoc Physicians India; 1999 Jun; 47(6):644. PubMed ID: 10999171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Megaloblastic anemia due to anticonvulsant therapy].
    Mozziconacci P; Attai C; Pham-Huu-Trung ; Boisse J; Piussan C
    Ann Pediatr (Paris); 1967; 14(6):466-70. PubMed ID: 5618046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side-effects of antiepileptic agents].
    Lunde PK
    Tidsskr Nor Laegeforen; 1971 Apr; 91(12):894-6. PubMed ID: 5554785
    [No Abstract]   [Full Text] [Related]  

  • 15. Is phenytoin carcinogenic?
    Lancet; 1971 Nov; 2(7733):1071-2. PubMed ID: 4106919
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticonvulsant hypersensitivity syndrome.
    Vittorio CC; Muglia JJ
    Arch Intern Med; 1995 Nov; 155(21):2285-90. PubMed ID: 7487252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reticular hyperplasia following hydantoin derivatives].
    Wasik F; Domanasiewicz M; Gasior B
    Hautarzt; 1975 May; 26(5):273-5. PubMed ID: 125251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
    Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydantoin-induced pseudo-pseudolymphoma.
    Gams RA; Neal JA; Conrad FG
    Ann Intern Med; 1968 Sep; 69(3):557-68. PubMed ID: 4970555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.